Tcr2 Therapeutics Inc (TCRR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -40,399 | -151,822 | -91,317 | -60,723 | -29,122 |
| Depreciation Amortization | 615 | 3,046 | 2,300 | 1,410 | 706 |
| Income taxes - deferred | N/A | -293 | -293 | -293 | 21 |
| Accounts payable and accrued liabilities | 3,527 | 1,166 | -637 | -881 | 1,756 |
| Other Working Capital | -3,374 | 9,580 | 4,492 | 3,057 | -5,105 |
| Other Operating Activity | -379 | 36,862 | 8,951 | 6,765 | 610 |
| Operating Cash Flow | $-40,010 | $-101,461 | $-76,504 | $-50,665 | $-31,134 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 385 | -15,122 | -12,681 | -7,893 | -1,911 |
| Purchase Of Investment | -13,699 | -267,522 | -215,619 | -186,006 | -148,382 |
| Sale Of Investment | 35,000 | 194,488 | 136,488 | 66,490 | 32,989 |
| Purchase Sale Intangibles | N/A | -330 | -330 | -295 | -66 |
| Other Investing Activity | 0 | -330 | -330 | -295 | -66 |
| Investing Cash Flow | $21,686 | $-88,486 | $-92,142 | $-127,704 | $-117,370 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 34 | 256 | 256 | 143 | 115 |
| Other Financing Activity | -10 | -131 | -172 | -131 | -56 |
| Financing Cash Flow | $24 | $125 | $84 | $12 | $59 |
| Beginning Cash Position | 33,898 | 223,720 | 223,720 | 223,720 | 223,720 |
| End Cash Position | 15,598 | 33,898 | 55,158 | 45,363 | 75,275 |
| Net Cash Flow | $-18,300 | $-189,822 | $-168,562 | $-178,357 | $-148,445 |
| Free Cash Flow | |||||
| Operating Cash Flow | -40,010 | -101,461 | -76,504 | -50,665 | -31,134 |
| Capital Expenditure | -158 | -15,122 | -12,681 | -7,893 | -1,911 |
| Free Cash Flow | -40,168 | -116,583 | -89,185 | -58,558 | -33,045 |